doi: 10.1182/blood.V126.23.3059.3059 Summary Keywords CLL - chronic lymphoblastic leukemia, BTK - Brutons tyrosine kinase, Bcl-2 inhibitor, Mcl-1 inhibitor, ibrutinib, venetoclax, glutamine (Gln) metabolism Citation Timofeeva N, Ayres ML, Baran N, Santiago-OFarrill JM, Bildik G, Lu Z, Konopleva M and Gandhi V (2023) Preclinical investigations of the efficacy of the glutaminase inhibitor CB-839 alone and in combinations in chronic lymphocytic leukemia
However, large molecular substances are confined within the intestinal lumen due to their inability to pass through tightly connected narrow channels
DCosta VM, McGrann KM, Hughes DW, Wright GD
Differential regulation of redox proteins and chaperones in HbEbeta-thalassemia erythrocyte proteome
What is most important is the dose